Yajas Shah Selected Research

Dipeptides

1/2019

L3MBTL1 regulates ALS/FTD-associated proteotoxicity and quality control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yajas Shah Research Topics

Disease

2	Brain Neoplasms (Brain Tumor) 12/2023 - 01/2019
2	Neoplasms (Cancer) 12/2021 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 04/2024
1	Lung Neoplasms (Lung Cancer) 10/2023
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Melanoma (Melanoma, Malignant) 01/2020
1	Frontotemporal Dementia (Semantic Dementia) 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2019
1	Blood Proteins (Serum Proteins)IBA 04/2024
1	SenotherapeuticsIBA 12/2023
1	Doxycycline (Periostat)FDA LinkGeneric 10/2023
1	Capsules (Microcapsules)IBA 10/2023
1	CytokinesIBA 01/2020
1	B-Cell Activating FactorIBA 01/2020
1	LigandsIBA 01/2020
1	ChemokinesIBA 01/2020
1	DipeptidesIBA 01/2019
1	Superoxide Dismutase-1IBA 01/2019

Therapy/Procedure

2	Immunotherapy 12/2023 - 01/2020
2	Therapeutics 12/2021 - 01/2020
1	Aftercare (After-Treatment) 12/2023